找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nanomedicine for Cancer Diagnosis and Therapy; Arshi Malik,Sarah Afaq,Mohammed Tarique Book 2021 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: ABS
31#
發(fā)表于 2025-3-27 00:54:38 | 只看該作者
Targeting Tumor Microenvironment Through Nanotheranostics,ancer tops the chart of global killers with an?exceptionally high mortality rate along with deaths due to cardiac attack and stroke. Several factors including complex tumor heterogeneity, ineffective delivery of chemotherapeutic drugs to the tumor sites along with high cytotoxicity and acquisition o
32#
發(fā)表于 2025-3-27 04:05:08 | 只看該作者
Therapeutic Applications of Noble Metal (Au, Ag, Pt)-Based Nanomedicines for Melanoma, the sun or due to genetic predisposition. Recent reports suggested that melanoma causes around 60,000 deaths worldwide. Conventional therapeutic approaches that are being applied for the treatment of melanoma include chemotherapy, surgery, immunotherapy, and radiation. However, the adverse side eff
33#
發(fā)表于 2025-3-27 08:01:36 | 只看該作者
Ethics in Nanomedicine,edical curriculum. As various approaches in Nanomedicine had progressed with enormous promise toward theranostic interventions, ethical queries also arise in conjunction. Nanomedicine is a unique niche in various facets, but it comes along with indications of dangers and uncertainties not confronted
34#
發(fā)表于 2025-3-27 12:09:15 | 只看該作者
35#
發(fā)表于 2025-3-27 14:39:04 | 只看該作者
f the new methodology, to yield the required development effort for the traditional case that can be compared to the measured effort with the proposed methodology. Compared with the traditional development of processes, a savings of 27% was achieved. There are currently process development methodolo
36#
發(fā)表于 2025-3-27 20:28:49 | 只看該作者
37#
發(fā)表于 2025-3-28 01:57:23 | 只看該作者
38#
發(fā)表于 2025-3-28 04:59:51 | 只看該作者
39#
發(fā)表于 2025-3-28 06:45:44 | 只看該作者
40#
發(fā)表于 2025-3-28 11:40:56 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 20:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
凤凰县| 射洪县| 偃师市| 庄河市| 梅河口市| 肃北| 芮城县| 桑植县| 玉屏| 怀远县| 勐海县| 龙江县| 闵行区| 宝鸡市| 安龙县| 长宁县| 甘肃省| 三穗县| 潮安县| 博湖县| 保山市| 高要市| 南城县| 临城县| 平山县| 正阳县| 衡阳市| 寿宁县| 和顺县| 民乐县| 楚雄市| 青岛市| 遵化市| 上高县| 酒泉市| 磐安县| 遵义市| 女性| 衡东县| 蒲江县| 庄河市|